Immediate Impact

5 by Nobel laureates 8 from Science/Nature 67 standout
Sub-graph 1 of 19

Citing Papers

A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
2024 Standout
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
2024 Standout
17 intermediate papers

Works of Gerry MacQuillan being referenced

Ad Libitum Mediterranean and Low‐Fat Diets Both Significantly Reduce Hepatic Steatosis: A Randomized Controlled Trial
2018
Nonalcoholic fatty liver disease‐related cirrhosis is commonly unrecognized and associated with hepatocellular carcinoma
2017
and 3 more

Author Peers

Author Last Decade Papers Cites
Gerry MacQuillan 904 1168 244 251 69 1.7k
Amanda Nicoll 766 932 226 157 90 2.1k
Seong Hee Kang 1052 1125 353 163 87 1.9k
Mark Wright 1093 1126 228 108 78 2.0k
Steven Masson 680 1120 282 346 77 1.9k
Katharina Staufer 943 1007 325 151 56 1.8k
Fabio Salvatore Macaluso 675 1106 252 130 95 1.7k
Stefano Gitto 1092 1144 469 113 82 1.7k
Walid S. Ayoub 949 1020 367 161 58 1.9k
N Raknerud 638 944 200 72 43 1.6k
Cristina Rigamonti 1224 1509 297 90 67 2.0k

All Works

Loading papers...

Rankless by CCL
2026